Answer
The safety and efficacy of siponimod fumaric acid in children and adolescents aged 0 to 18 years have not yet been established, and no data are available.
Sources for this answer
- Mayzent 0.25 mg, 1 mg & 2 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 8Document updated
Sources checked